{"id":"W4282935821","doi":"10.1158/1078-0432.ccr-21-4020","title":"First-In-Human Phase I Study of the OX40 Agonist MOXR0916 in Patients with Advanced Solid Tumors","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; Jewish General Hospital","funders":"National Center for Advancing Translational Sciences; National Cancer Institute; Genentech","keywords":"Medicine; Renal cell carcinoma; Internal medicine; Adverse effect; Pharmacokinetics; Cancer; Nausea; Agonist; Oncology; Gastroenterology; Receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001256532,0.001382167,0.001547152,0.0002308635,0.0003609594,0.0006451012,0.0006739275,0.0007904868,0.003533021],"category_scores_gemma":[0.0004415018,0.0005208289,0.0008555035,0.0002567371,0.0007547009,0.0005704135,0.0002968739,0.002759179,0.0008569003],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006995248,"about_ca_system_score_gemma":0.001383972,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006540726,"about_ca_topic_score_gemma":0.002222211,"domain_scores_codex":[0.999653,0.0001793451,0.00001401914,0.00004327879,0.00003023777,0.00008007609],"domain_scores_gemma":[0.9996111,0.00005410185,0.00008039418,0.00003735166,0.00002813054,0.0001888976],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.3759091,0.1222372,0.01655209,0.002393296,0.001781705,0.000829651,0.0008506664,0.006086911,0.2648284,0.0005373893,0.00848392,0.1995098],"study_design_scores_gemma":[0.2319172,0.7260371,0.015608,0.00005507723,0.0004118873,0.0007902427,0.00007643144,0.001002136,0.01754603,0.0001555847,0.006369456,0.00003093485],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9925417,0.002197693,0.0006337144,0.0002934396,0.00007513561,0.002126721,0.0008055638,0.00009497334,0.001231152],"genre_scores_gemma":[0.9898223,0.001961238,0.001845806,0.0003773636,0.0001145023,0.00146697,0.001601693,0.0000352423,0.002775068],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003533021,"threshold_uncertainty_score":0.01181918,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1139093973048907,"score_gpt":0.5092122895520722,"score_spread":0.3953028922471815,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}